Peter S Knight - Net Worth and Insider Trading

Peter S Knight Net Worth

The estimated net worth of Peter S Knight is at least $59,936 dollars as of 2024-05-26. Peter S Knight is the Director of bioAffinity Technologies Inc and owns about 22,448 shares of bioAffinity Technologies Inc (BIAF) stock worth over $59,936. Details can be seen in Peter S Knight's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter S Knight has not made any transactions after 2022-08-31 and currently still holds the listed stock(s).

Transaction Summary of Peter S Knight

To

Peter S Knight Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter S Knight owns 2 companies in total, including CASI Pharmaceuticals Inc (CASI) , and bioAffinity Technologies Inc (BIAF) .

Click here to see the complete history of Peter S Knight’s form 4 insider trades.

Insider Ownership Summary of Peter S Knight

Ticker Comapny Transaction Date Type of Owner
CASI CASI Pharmaceuticals Inc 2003-10-21 director
BIAF bioAffinity Technologies Inc 2022-08-31 director

Peter S Knight Latest Holdings Summary

Peter S Knight currently owns a total of 1 stock. Peter S Knight owns 22,448 shares of bioAffinity Technologies Inc (BIAF) as of August 31, 2022, with a value of $59,936.

Latest Holdings of Peter S Knight

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BIAF bioAffinity Technologies Inc 2022-08-31 22,448 2.67 59,936

Holding Weightings of Peter S Knight


Peter S Knight Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter S Knight has made a total of 1 transactions in bioAffinity Technologies Inc (BIAF) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in bioAffinity Technologies Inc is the acquisition of 8,163 shares on August 31, 2022, which cost Peter S Knight around $24,897.

Insider Trading History of Peter S Knight

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter S Knight Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Peter S Knight Ownership Network

Ownership Network List of Peter S Knight

No Data

Ownership Network Relation of Peter S Knight


Peter S Knight Owned Company Details

What does CASI Pharmaceuticals Inc do?

Who are the key executives at CASI Pharmaceuticals Inc?

Peter S Knight is the director of CASI Pharmaceuticals Inc. Other key executives at CASI Pharmaceuticals Inc include director & 10 percent owner & Chairman and CEO Wei-wu He , Chief Financial Officer Weihao Xu , and President Larry Zhang .

CASI Pharmaceuticals Inc (CASI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CASI Pharmaceuticals Inc (CASI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CASI Pharmaceuticals Inc (CASI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CASI Pharmaceuticals Inc (CASI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CASI Pharmaceuticals Inc Insider Transactions

No Available Data

Peter S Knight Mailing Address

Above is the net worth, insider trading, and ownership report for Peter S Knight. You might contact Peter S Knight via mailing address: 6702 Stein Circle, #642, P.o. Box 4138, Park City Ut 84060.

Discussions on Peter S Knight

No discussions yet.